COMBINATION OF RIBOCICLIB AND DABRAFENIB FOR TREATING OR PREVENTING CANCER

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP16763589.5

公开号：

EP3340987A1

申请日:

2016.08.25

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present disclosure relates to pharmaceutical combinations comprising a cyclin dependent kinase 4/6 (CDK4/6) inhibitor compound, (b) a B-Raf inhibitor compound, and optionally (c) an alpha-isoform specific phosphatidylinositol 3-kinase (PI3K) inhibitor compound, for the treatment or prevention of cancer, as well as related pharmaceutical compositions, uses, and methods of treatment or prevention of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/